Medtronic (MDT) HR chief sells 3,102 shares, retains over 35,000

Rhea-AI Filing Summary

Medtronic plc senior vice president and chief HR officer Walter Matthew R. completed an open-market sale of 3,102 Ordinary Shares of Medtronic on July 8, 2026 at a price of $83.15 per share.

After this transaction, he directly owns 35,694 Ordinary Shares, so the sale represents a relatively small portion of his overall holdings. His reported holdings also include 107 shares acquired through Medtronic’s Employee Stock Ownership Plan since his prior report.

Insider Trade Summary 10b5-1

Net Seller: 3,102 shares ($257,931)

Net Sell 1 txn

Insider Walter Matthew R.

Role SVP, Chief HR Officer

Sold 3,102 shs ($258K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	3,102	$83.15	$258K

Holdings After Transaction: Ordinary Shares — 35,694 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 3,102 shares Sale price per share: $83.15 per share Shares owned after transaction: 35,694 shares +1 more

4 metrics

Shares sold 3,102 shares Open-market sale of Ordinary Shares on July 8, 2026

Sale price per share $83.15 per share Price for the 3,102 Ordinary Shares sold

Shares owned after transaction 35,694 shares Direct holdings following the reported sale

Employee Stock Ownership Plan shares 107 shares Shares acquired under Medtronic’s ESOP since last report

Key Terms

open-market sale, Ordinary Shares, Employee Stock Ownership Plan

3 terms

open-market sale financial

"The transaction is classified as an open-market sale of Ordinary Shares."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Ordinary Shares financial

"The filing reports a sale of Medtronic’s Ordinary Shares by the executive."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Employee Stock Ownership Plan financial

"Includes 107 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report."

An employee stock ownership plan (ESOP) is a company-run program that gives workers ownership stakes by allocating or letting them buy company shares, often through a retirement-style account. For investors, ESOPs matter because they align employees’ incentives with company performance—like turning staff into shareholders—which can boost productivity and long-term value but may also concentrate employee retirement savings in company stock, affecting financial risk and share demand.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/09/2026 - 04:26 PM Accepted by SEC EDGAR 07/09/2026 - 04:26 PM Learn about SEC filing dates

FAQ

What insider transaction did Medtronic (MDT) report for Walter Matthew R.?

Medtronic reported that SVP and Chief HR Officer Walter Matthew R. sold 3,102 Ordinary Shares in an open-market transaction. The sale was reported on a Form 4 insider filing and involved Medtronic plc’s Ordinary Shares.

How many Medtronic (MDT) shares did the executive sell and at what price?

Walter Matthew R. sold 3,102 Medtronic Ordinary Shares at a price of $83.15 per share. This was an open-market sale, as disclosed in the Form 4 insider trading report.

How many Medtronic (MDT) shares does Walter Matthew R. own after the sale?

Following the sale, Walter Matthew R. directly holds 35,694 Medtronic Ordinary Shares. This remaining stake shows he continues to have a significant personal equity interest in the company after the reported transaction.

What type of security was involved in the Medtronic (MDT) insider sale?

The transaction involved Medtronic’s Ordinary Shares, which are the company’s standard equity securities. No options or derivative securities were exercised or converted in connection with this Form 4 filing.

Does the Form 4 note any Medtronic (MDT) shares from employee stock plans?

Yes. The filing states that the reported holdings include 107 shares acquired under Medtronic’s Employee Stock Ownership Plan since the last report. These plan-acquired shares are part of Walter Matthew R.’s direct ownership position.

Was this Medtronic (MDT) insider transaction a purchase or a sale?

This insider transaction was a sale. The Form 4 classifies it as an open-market sale of Ordinary Shares, with the transaction direction identified as a sell rather than a purchase or option exercise.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Walter Matthew R.

(Last) (First) (Middle)

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS MINNESOTA 55432

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief HR Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	07/08/2026		S		3,102	D	$83.15	35,694(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 107 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person.

Remarks:

	/s/ Patricia Walesiewicz, attorney-in-fact	07/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)